FIELD: medicine.
SUBSTANCE: method involves analyzing blood serum for alpha-2-glycoprotein associated with pregnancy taking concentration determined before administering hormone therapy for individual reference value and then, blood serum is analyzed once every half-year during the whole hormone replacement therapy application period. Alpha-2-glycoprotein associated with pregnancy having unchanged concentration or its concentration being increased by 50% when compared to the individual reference value, hormone replacement therapy application is to be continued. The concentration growing more than 50% high, when compared to the individual reference value, hormone replacement therapy application is to be prohibited.
EFFECT: enhanced effectiveness of treatment.
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR PREDICTION OF DEVELOPING COMPLICATIONS IN WOMEN SUFFERING CLIMACTERIC SYNDROME AND MASTOPATHY AND EMPLOYING HORMON REPLACEMENT | 2010 | 
 | RU2426994C1 | 
| WAY OF FORECASTING OF OCCURRENCE OF COMPLICATIONS AT WOMEN WITH CLIMACTERIC SYNDROME AGAINST REPLACEABLE HORMONAL THERAPY | 2008 | 
 | RU2360610C1 | 
| METHOD FOR PREDICTING CLINICAL EFFECTIVENESS OF CLIMACTERIC SYNDROME MELATONIN IN FEMALES IN PERIMENOPAUSAL AND POSTMENOPAUSAL WOMEN | 2019 | 
 | RU2723764C1 | 
| METHOD FOR INDIVIDUAL PREVENTION OF OESTROGEN-DEPENDENT DISEASES IN HEALTHY FEMALES AND FEMALES SUFFERING CARDIOVASCULAR RISK FACTORS AT AGE OF 45-60 YEARS OLD | 2013 | 
 | RU2527357C1 | 
| METHOD FOR DETERMINATION AND PREDICTION OF WOMAN'S HEALTH IN PERIMENOPAUSE AND POSTMENOPAUSE | 2016 | 
 | RU2633926C1 | 
| AGENT FOR CORRECTING MENSTRUAL IRREGULARITIES, MENOPAUSAL DISORDERS | 2022 | 
 | RU2801514C1 | 
| METHOD OF TREATING GENITOURINARY SYNDROME IN MENOPAUSAL WOMEN BY MEANS OF PLACENTAL THERAPY | 2019 | 
 | RU2710015C1 | 
| APPLICATION OF PREPARATION LAENNEK FOR REDUCTION OR ELIMINATION OF MANIFESTATION OF MENOPAUSAL SYMPTOMS (VERSIONS) | 2016 | 
 | RU2611370C1 | 
| METHOD OF PREVENTION AND TREATMENT OF CLIMACTERIC SYNDROME IN WOMEN OF PREMENOPAUSAL PERIOD | 2011 | 
 | RU2477080C1 | 
| METHOD FOR CORRECTION OF DYSLIPIDEMIA IN WOMEN WITH METABOLIC SYNDROME DURING MENOPAUSAL TRANSITION | 2021 | 
 | RU2771426C1 | 
Authors
Dates
2007-07-20—Published
2005-06-14—Filed